These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 6436758

  • 21. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ.
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4546-50. PubMed ID: 6192438
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M, Morin N, Grégoire L, Rajput A, Rajput AH, Di Paolo T.
    Biochem Pharmacol; 2016 Jun 01; 109():62-69. PubMed ID: 27038656
    [Abstract] [Full Text] [Related]

  • 27. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 01; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent.
    Zimmerman DM, Cantrell BE, Reel JK, Hemrick-Luecke SK, Fuller RW.
    J Med Chem; 1986 Aug 01; 29(8):1517-20. PubMed ID: 3488406
    [Abstract] [Full Text] [Related]

  • 29. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density.
    Joyce JN, Marshall JF, Bankiewicz KS, Kopin IJ, Jacobowitz DM.
    Brain Res; 1986 Sep 24; 382(2):360-4. PubMed ID: 2944565
    [Abstract] [Full Text] [Related]

  • 30. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H, Henning K, Eckhardt H, Przuntek H.
    Arzneimittelforschung; 1985 Sep 24; 35(2):481-2. PubMed ID: 2581589
    [Abstract] [Full Text] [Related]

  • 31. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
    Taquet H, Nomoto M, Rose S, Jenner P, Javoy-Agid F, Mauborgne A, Benoliel JJ, Marsden CD, Legrand JC, Agid Y.
    Neuropeptides; 1988 Oct 24; 12(3):105-10. PubMed ID: 2468106
    [Abstract] [Full Text] [Related]

  • 32. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
    Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L.
    Proc Natl Acad Sci U S A; 1987 Aug 24; 84(16):5995-9. PubMed ID: 3497401
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment.
    Alexander GM, Schwartzman RJ, Grothusen JR, Brainard L, Gordon SW.
    Brain Res; 1993 Oct 22; 625(2):276-82. PubMed ID: 8275309
    [Abstract] [Full Text] [Related]

  • 37. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.
    Elsworth JD, Deutch AY, Redmond DE, Taylor JR, Sladek JR, Roth RH.
    Neuroscience; 1989 Oct 22; 33(2):323-31. PubMed ID: 2622529
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I, Oset C, Luquin MR, Herrero MT, Obeso JA, Del Río J.
    Neurosci Lett; 1994 Jul 04; 175(1-2):121-5. PubMed ID: 7970192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.